Dr. Rhee earned his MD/PhD from the University of California, Irvine, followed by clinical training in internal medicine and infectious diseases and postdoctoral training in the laboratory of Carl Nathan, at Weill Cornell Medical College. The focus of Dr. Rhee’s lab is the development and application of metabolomic technologies to study the physiology and pharmacology of Mycobacterium tuberculosis, the causative agent of TB.